Overview

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have small cell lung cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
National Cancer Institute (NCI)
Treatments:
Carboplatin
Etoposide
Ifosfamide
Isophosphamide mustard
Topotecan